{"id":"W2538510330","doi":"10.1182/blood.v114.22.4286.4286","title":"Comparison of Healthcare Utilization and Costs Between Nilotinib and Dasatinib as Second Line Therapies in Chronic Myeloid Leukemia.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Nilotinib; Medicine; Dasatinib; Internal medicine; Myeloid leukemia; Medical prescription; Pharmacy; Imatinib; Pharmacology; Family medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001555429,0.0002317668,0.0006434534,0.001176391,0.0001659139,0.0007178074,0.0003574701,0.0003622734,0.001270085],"category_scores_gemma":[0.005395836,0.0001673906,0.001220795,0.001700606,0.0002008624,0.0004751336,0.0005067537,0.000412046,0.00008876473],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001481732,"about_ca_system_score_gemma":0.0007370439,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005651788,"about_ca_topic_score_gemma":0.005800593,"domain_scores_codex":[0.9975051,0.001129261,0.0003604693,0.0003491314,0.000414508,0.0002416045],"domain_scores_gemma":[0.9960038,0.001631993,0.001744159,0.00008207244,0.000192609,0.000345304],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004158264,0.0001893907,0.9862376,0.0001410738,0.0009707686,0.00006731715,0.00004971961,0.0009931,0.0001628936,0.0001675135,0.0004364908,0.006425816],"study_design_scores_gemma":[0.0002569054,0.001022643,0.9939013,0.0000368009,0.0002939657,0.0001893207,0.0001988156,0.003290266,0.000162828,0.00008674136,0.0005485664,0.00001184906],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965566,0.001003801,0.00006564693,0.0000764461,0.000007739573,0.00002644846,0.001957007,0.000002089134,0.0003042415],"genre_scores_gemma":[0.9976079,0.0002078242,0.0000761023,0.0000243517,0.00001231523,0.00002387853,0.001991618,0.000001101669,0.0000548435],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005651788,"threshold_uncertainty_score":0.0112378,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04967079517563694,"score_gpt":0.3562436461687651,"score_spread":0.3065728509931281,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}